-
32004L0027R(03)
This corrigendum does not concern the English version.
-
32010L0084R(03)
This corrigendum does not concern the English version.
-
62012CN0493
Case C-493/12: Reference for a preliminary ruling from High Court of Justice (Chancery Division) (United Kingdom) made on 5 November 2012 — Eli Lilly and Company Ltd v Human Genome Sciences Inc
OJ C 9, 12.1.2013, p. 33–33 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62012CN0367
Case C-367/12: Reference for a preliminary ruling from the Unabhängiger Verwaltungssenat des Landes Oberösterreich (Austria) lodged on 1 August 2012 — Corinna Prinz-Stremitzer, Susanne Sokoll-Seebacher
OJ C 331, 27.10.2012, p. 13–13 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62011CA0308
Case C-308/11: Judgment of the Court (Fifth Chamber) of 6 September 2012 (reference for a preliminary ruling from the Oberlandesgericht Frankfurt am Main — Germany) — Chemische Fabrik Kreussler & Co. GmbH v Sunstar Deutschland GmbH, formerly John O. Butler GmbH (Directive 2001/83/EC — Medicinal products for human use — Article 1(2)(b) — Meaning of ‘medicinal product by function’ — Definition of the term ‘pharmacological action’ )
OJ C 331, 27.10.2012, p. 9–9 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
52012XC1006(01)
Commission Guideline — Guidance on posting and publication of result-related information on clinical trials in relation to the implementation of Article 57(2) of Regulation (EC) No 726/2004 and Article 41(2) of Regulation (EC) No 1901/2006
OJ C 302, 6.10.2012, p. 7–10 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62011CA0145
Case C-145/11: Judgment of the Court (Third Chamber) of 19 July 2012 — European Commission v French Republic (Failure of a Member State to fulfil obligations — Directive 2001/82/EC — Veterinary medicinal products — Decentralised procedure for the grant of marketing authorisation for a veterinary medicinal product in a number of Member States — Generic medicinal products similar to the reference medicinal products already authorised — Refusal to approve request by a Member State — Composition and form of the medicinal product)
OJ C 295, 29.9.2012, p. 10–10 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
52011AP0056
Falsified medicinal products ***I European Parliament legislative resolution of 16 February 2011 on the proposal for a directive of the European Parliament and of the Council amending Directive 2001/83/EC as regards the prevention of the entry into the legal supply chain of medicinal products which are falsified in relation to their identity, history or source (COM(2008)0668 – C6-0513/2008 – 2008/0261(COD))
P7_TC1-COD(2008)0261 Position of the European Parliament adopted at first reading on 16 February 2011 with a view to the adoption of Directive 2011/…/EU of the European Parliament and of the Council amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products
OJ C 188E , 28.6.2012, p. 91–92 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
52008XC0125(01)R(01)
Corrigendum to the summary of Community decisions on marketing authorizations in respect of medicinal products from 1 December 2007 to 31 December 2007 ( OJ C 19, 25.1.2008 )
OJ C 107, 13.4.2012, p. 14–14 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
52010AP0430
Information on medicinal products (Community procedures for the authorisation and supervision of medicinal products) ***I European Parliament legislative resolution of 24 November 2010 on the proposal for a regulation of the European Parliament and of the Council amending, as regards information to the general public on medicinal products for human use subject to medical prescription, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (COM(2008)0662 – C6-0517/2008 – 2008/0255(COD))
P7_TC1-COD(2008)0255 Position of the European Parliament adopted at first reading on 24 November 2010 with a view to the adoption of Regulation (EU) No …/2011 of the European Parliament and of the Council amending, as regards information to the general public on medicinal products for human use subject to medical prescription, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency Text with EEA relevance
OJ C 99E , 3.4.2012, p. 203–207 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
